Malignant Nasopharyngeal Neoplasm

cancer

Identifier: CI-CAN-00005902
Entity page: /cancer/malignant-nasopharyngeal-neoplasm ↗
Edges: 841

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Malignant Nasopharyngeal Neoplasm approved for …APPROVED_FORderived1 of 1
← approved for	Toripalimabmonoclonal antibody FDA (US) · approved · 2023-10-27 · in combination with cisplatin and gemcitabine, for first-line treatment of adults with metastatic or with recurrent locally advanced nasoph…	—	approved	Nasopharyngeal Carcinoma	1	Regulatory	openfda	graph →
Malignant Nasopharyngeal Neoplasm …

Malignant Nasopharyngeal Neoplasm studied in …STUDIED_INderived10 of 771show all (up to 200)
→ studied in	NCT04085900recruiting Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06479811Phase 1 · recruiting [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06980038Phase 2 · recruiting Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05290194Phase 2 · withdrawn Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05904080Phase 2 · suspended Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer · condition mapped CURATED_BROADER · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped CURATED_EXACT · 771 trials mapped (303 active)	—	—	Malignant Nasopharyngeal Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06629597Phase 3 · active not recruiting A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301) · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07177443Phase 3 · recruiting Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma · condition mapped CURATED_BROADER · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07824856Phase 2 · not yet recruiting Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal Carcinoma · condition mapped ONTOLOGY_EXACT · 771 trials mapped (303 active)	—	—	Nasopharyngeal Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains